scispace - formally typeset
A

Arduino A. Mangoni

Researcher at Flinders Medical Centre

Publications -  397
Citations -  10350

Arduino A. Mangoni is an academic researcher from Flinders Medical Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 42, co-authored 348 publications receiving 7835 citations. Previous affiliations of Arduino A. Mangoni include University of Cambridge & King's College London.

Papers
More filters
Journal ArticleDOI

Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis

TL;DR: A meta‐analysis is conducted to review the available evidence regarding the associations between peripheral blood neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to-lymphocytes ratio (PLR), and the presence of rheumatoid arthritis (RA).
Journal ArticleDOI

Outcome following isolated tricuspid valve replacement.

TL;DR: Isolated tricuspid valve replacement is characterized by a poor short and long-term outcome, with the median survival only 1.2 years and anasarca was the only predictor of short-term mortality.
Journal ArticleDOI

Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data

TL;DR: Despite increasing evidence of adverse outcomes, the proportion of older people prescribed anticholinergic medications and the proportion with a high anticholineergic exposure has increased between 1995 and 2010.
Journal ArticleDOI

Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity.

TL;DR: Data derived from in vitro models used to generate NSAID IC50 values informed the ‘imbalance hypothesis’ that the cardiovascular risk of NSAIDs results from an imbalance in the detrimental actions of COX-1-derived thromboxane A2 and the beneficial actions ofCOX-2-derived prostacyclin (PGI2).
Journal ArticleDOI

Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia

TL;DR: In subjects with a marked increase in serum cholesterol due to FHC, not only arteriolar dilatation, but also RAC and distensibility are markedly impaired, and this impairment can be favourably affected by an effective lipid lowering treatment of long duration.